Interferon response of the cystic fibrosis bronchial epithelium to major and minor group rhinovirus infection

Journal of Cystic Fibrosis

Volumn 15, Issue 3, 2016, Pages 332-339

  Schögler, Aline ^a,b   Stokes, Andrea B ^a,b   Casaulta, Carmen ^a   Regamey, Nicolas ^c   Edwards, Michael R ^d   Johnston, Sebastian L ^d   Jung, Andreas ^e   Moeller, Alexander ^e   Geiser, Thomas ^b,f   Alves, Marco P ^a,b  

^a UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

^c CHILDREN S HOSPITAL   (Switzerland)

^d NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^e UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^f UNIVERSITY OF BERN   (Switzerland)

Author keywords

Bronchial epithelial cells; Cystic fibrosis; Interferon; Rhinovirus

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; INTERLEUKIN 6; INTERLEUKIN 8; MYXOVIRUS RESISTANCE PROTEIN A; PATTERN RECOGNITION RECEPTOR; PROTEIN KINASE R; RETINOIC ACID INDUCIBLE PROTEIN I; TOLL LIKE RECEPTOR 3; UNCLASSIFIED DRUG; VIPERIN; INTERFERON INDUCING AGENT;

ADOLESCENT; ARTICLE; BRONCHUS MUCOSA; CHILD; CONTROLLED STUDY; CYSTIC FIBROSIS; CYTOKINE RESPONSE; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN CELL; INFLAMMATION; INNATE IMMUNITY; MALE; PILOT STUDY; PRESCHOOL CHILD; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RHINOVIRUS INFECTION; SCHOOL CHILD; CELL CULTURE TECHNIQUE; COMPLICATION; IMMUNOLOGY; ISOLATION AND PURIFICATION; MUCOSAL IMMUNITY; PICORNAVIRUS INFECTION; RESPIRATORY MUCOSA; RHINOVIRUS; VIROLOGY;

CELL CULTURE TECHNIQUES; CYSTIC FIBROSIS; HUMANS; IMMUNITY, MUCOSAL; INTERFERON INDUCERS; INTERFERONS; PICORNAVIRIDAE INFECTIONS; RESPIRATORY MUCOSA; RHINOVIRUS;

EID: 84969513613     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2015.10.013     Document Type: Article

References (37)

1. Hofer F., Gruenberger M., Kowalski H., Machat H., Huettinger M., Kuechler E., et al. Members of the low density lipoprotein receptor family mediate cell entry of a minor-group common cold virus. Proc Natl Acad Sci U S A 1994, 91(5):1839-1842.
2. Greve J.M., Davis G., Meyer A.M., Forte C.P., Yost S.C., Marlor C.W., et al. The major human rhinovirus receptor is ICAM-1. Cell 1989, 56(5):839-847.
3. Monto A.S., Malosh R.E., Petrie J.G., Thompson M.G., Ohmit S.E. Frequency of acute respiratory illnesses and circulation of respiratory viruses in households with children over 3 surveillance seasons. J Infect Dis 2014, 210(11):1792-1799.
4. Wat D., Gelder C., Hibbitts S., Cafferty F., Bowler I., Pierrepoint M., et al. The role of respiratory viruses in cystic fibrosis. J Cyst Fibros 2008, 7(4):320-328.
5. de Almeida M.B., Zerbinati R.M., Tateno A.F., Oliveira C.M., Romao R.M., Rodrigues J.C., et al. Rhinovirus C and respiratory exacerbations in children with cystic fibrosis. Emerg Infect Dis 2010, 16(6):996-999.
6. Collinson J., Nicholson K.G., Cancio E., Ashman J., Ireland D.C., Hammersley V., et al. Effects of upper respiratory tract infections in patients with cystic fibrosis. Thorax 1996, 51(11):1115-1122.
7. Sutanto E.N., Kicic A., Foo C.J., Stevens P.T., Mullane D., Knight D.A., et al. Innate inflammatory responses of pediatric cystic fibrosis airway epithelial cells: effects of nonviral and viral stimulation. Am J Respir Cell Mol Biol 2011, 44(6):761-767.
8. Zheng S., De B.P., Choudhary S., Comhair S.A., Goggans T., Slee R., et al. Impaired innate host defense causes susceptibility to respiratory virus infections in cystic fibrosis. Immunity 2003, 18(5):619-630.
9. Schogler A., Kopf B.S., Edwards M.R., Johnston S.L., Casaulta C., Kieninger E., et al. Novel antiviral properties of azithromycin in cystic fibrosis airway epithelial cells. Eur Respir J 2015, 45(2):428-439.
10. Kieninger E., Singer F., Tapparel C., Alves M.P., Latzin P., Tan H.L., et al. High rhinovirus burden in lower airways of children with cystic fibrosis. Chest 2013, 143(3):782-790.
11. Johnston N.W., Johnston S.L., Duncan J.M., Greene J.M., Kebadze T., Keith P.K., et al. The September epidemic of asthma exacerbations in children: a search for etiology. J Allergy Clin Immunol 2005, 115(1):132-138.
12. Wark P.A., Johnston S.L., Bucchieri F., Powell R., Puddicombe S., Laza-Stanca V., et al. Asthmatic bronchial epithelial cells have a deficient innate immune response to infection with rhinovirus. J Exp Med 2005, 201(6):937-947.
13. Contoli M., Message S.D., Laza-Stanca V., Edwards M.R., Wark P.A., Bartlett N.W., et al. Role of deficient type III interferon-lambda production in asthma exacerbations. Nat Med 2006, 12(9):1023-1026.
14. Forbes R.L., Gibson P.G., Murphy V.E., Wark P.A. Impaired type I and III interferon response to rhinovirus infection during pregnancy and asthma. Thorax 2012, 67(3):209-214.
15. Sykes A., Edwards M.R., Macintyre J., del Rosario A., Bakhsoliani E., Trujillo-Torralbo M.B., et al. Rhinovirus 16-induced IFN-alpha and IFN-beta are deficient in bronchoalveolar lavage cells in asthmatic patients. J Allergy Clin Immunol 2012, 129(6):1506-1514.
16. Edwards M.R., Regamey N., Vareille M., Kieninger E., Gupta A., Shoemark A., et al. Impaired innate interferon induction in severe therapy resistant atopic asthmatic children. Mucosal Immunol 2013, 6(4):797-806.
17. Schneider D., Ganesan S., Comstock A.T., Meldrum C.A., Mahidhara R., Goldsmith A.M., et al. Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2010, 182(3):332-340.
18. Mallia P., Message S.D., Gielen V., Contoli M., Gray K., Kebadze T., et al. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 2011, 183(6):734-742.
19. Slater L., Bartlett N.W., Haas J.J., Zhu J., Message S.D., Walton R.P., et al. Co-ordinated role of TLR3, RIG-I and MDA5 in the innate response to rhinovirus in bronchial epithelium. PLoS Pathog 2010, 6(11).
20. Sykes A., Macintyre J., Edwards M.R., Del Rosario A., Haas J., Gielen V., et al. Rhinovirus-induced interferon production is not deficient in well controlled asthma. Thorax 2014, 69(3):240-246.
21. Nakagome K., Bochkov Y.A., Ashraf S., Brockman-Schneider R.A., Evans M.D., Pasic T.R., et al. Effects of rhinovirus species on viral replication and cytokine production. J Allergy Clin Immunol 2014, 134(2):332-341.
22. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25(4):402-408.
23. Baines K.J., Hsu A.C., Tooze M., Gunawardhana L.P., Gibson P.G., Wark P.A. Novel immune genes associated with excessive inflammatory and antiviral responses to rhinovirus in COPD. Respir Res 2013, 14:15.
24. Chattoraj S.S., Ganesan S., Faris A., Comstock A., Lee W.M., Sajjan U.S. Pseudomonas aeruginosa suppresses interferon response to rhinovirus infection in cystic fibrosis but not in normal bronchial epithelial cells. Infect Immun 2011, 79(10):4131-4145.
25. Chattoraj S.S., Ganesan S., Jones A.M., Helm J.M., Comstock A.T., Bright-Thomas R., et al. Rhinovirus infection liberates planktonic bacteria from biofilm and increases chemokine responses in cystic fibrosis airway epithelial cells. Thorax 2011, 66(4):333-339.
26. Stelzer-Braid S., Johal H., Skilbeck K., Steller A., Alsubie H., Tovey E., et al. Detection of viral and bacterial respiratory pathogens in patients with cystic fibrosis. J Virol Methods 2012, 186(1-2):109-112.
27. Wang Q., Nagarkar D.R., Bowman E.R., Schneider D., Gosangi B., Lei J., et al. Role of double-stranded RNA pattern recognition receptors in rhinovirus-induced airway epithelial cell responses. J Immunol 2009, 183(11):6989-6997.
28. 2+ i signals in human cystic fibrosis airway epithelia. J Biol Chem 2005, 280(11):10202-10209.
29. Zaheer R.S., Proud D. Human rhinovirus-induced epithelial production of CXCL10 is dependent upon IFN regulatory factor-1. Am J Respir Cell Mol Biol 2010, 43(4):413-421.
30. Taima K., Imaizumi T., Yamashita K., Ishikawa A., Fujita T., Yoshida H., et al. Expression of IP-10/CXCL10 is upregulated by double-stranded RNA in BEAS-2B bronchial epithelial cells. Respiration 2006, 73(3):360-364.
31. Wark P.A., Grissell T., Davies B., See H., Gibson P.G. Diversity in the bronchial epithelial cell response to infection with different rhinovirus strains. Respirology 2009, 14(2):180-186.
32. Schuler B.A., Schreiber M.T., Li L., Mokry M., Kingdon M.L., Raugi D.N., et al. Major and minor group rhinoviruses elicit differential signaling and cytokine responses as a function of receptor-mediated signal transduction. PLoS One 2014, 9(4).
33. Flight W.G., Bright-Thomas R.J., Tilston P., Mutton K.J., Guiver M., Morris J., et al. Incidence and clinical impact of respiratory viruses in adults with cystic fibrosis. Thorax 2014, 69(3):247-253.
34. Wark P.A., Tooze M., Cheese L., Whitehead B., Gibson P.G., Wark K.F., et al. Viral infections trigger exacerbations of cystic fibrosis in adults and children. Eur Respir J 2012, 40(2):510-512.
35. Hoek R.A., Paats M.S., Pas S.D., Bakker M., Hoogsteden H.C., Boucher C.A., et al. Incidence of viral respiratory pathogens causing exacerbations in adult cystic fibrosis patients. Scand J Infect Dis 2013, 45(1):65-69.
36. Goffard A., Lambert V., Salleron J., Herwegh S., Engelmann I., Pinel C., et al. Virus and cystic fibrosis: rhinoviruses are associated with exacerbations in adult patients. J Clin Virol 2014, 60(2):147-153.
37. Ramirez I.A., Caverly L.L., Kalikin L.M., Goldsmith A.M., Lewis T.C., Burke D.T., et al. Differential responses to rhinovirus- and influenza-associated pulmonary exacerbations in patients with cystic fibrosis. Ann Am Thorac Soc 2014, 11(4):554-561.